Report Description

Forecast Period

2025-2029

Market Size (2023)

USD 62.12 Billion

Market Size (2029)

USD 87.94 Billion

CAGR (2024-2029)

6.45%

Fastest Growing Segment

Hospital Pharmacies

Largest Market

North America

Market Overview

Global Sleeping Aids Market was valued at USD 62.12 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.45% through 2029. The Sleep Aid Market has witnessed substantial growth and transformation as a crucial segment within the broader healthcare and wellness industry. This market caters to the escalating demand for solutions that address the prevalent and pervasive issue of sleep disorders, affecting millions of individuals globally. Sleep-related concerns have gained prominence due to various factors, including increased stress levels, lifestyle changes, and a growing awareness of the vital role sleep plays in overall health. As a result, the sleep aid market has become a focal point for consumers seeking effective and accessible remedies to improve their sleep quality and duration. One of the primary drivers propelling the sleep aid market is the rising prevalence of sleep disorders. Conditions such as insomnia, sleep apnea, restless legs syndrome, and circadian rhythm disorders have become increasingly common, impacting the daily lives and well-being of individuals across diverse age groups. The modern lifestyle, characterized by high stress levels, irregular work hours, and excessive screen time, contributes to the exacerbation of sleep-related issues. This prevalence has created a substantial market demand for a variety of sleep aid products and interventions. The growing awareness of the importance of sleep in maintaining overall health has significantly influenced consumer behavior. Recognizing the profound impact of quality sleep on mental, physical, and emotional well-being, individuals are increasingly seeking solutions to address sleep challenges. This awareness extends to the healthcare sector, with healthcare professionals emphasizing the significance of addressing sleep disorders for comprehensive health management.

Stress, a pervasive factor in contemporary lifestyles, plays a pivotal role in driving the demand for sleep aids. The pressures of work, academic responsibilities, and societal expectations contribute to heightened stress levels, leading to sleep disturbances. Consequently, individuals are turning to sleep aid products to alleviate stress-induced sleep problems and improve their sleep patterns. An aging population further amplifies the demand for sleep aid solutions. As individuals age, they may experience changes in sleep patterns, including difficulties falling asleep and staying asleep. The elderly demographic often seeks interventions to enhance the quality of their sleep, contributing to the growth of the sleep aid market.The escalating prevalence of mental health issues, such as anxiety and depression, has a direct impact on sleep quality. Individuals grappling with mental health challenges often experience disruptions in their sleep patterns. The recognition of this interconnectedness has led to an increased focus on developing sleep aid products that address both mental health concerns and sleep disorders.

Technological advancements have brought forth innovative solutions within the sleep aid market. Wearable devices, smart mattresses, and sleep tracking applications have gained popularity, allowing individuals to monitor and optimize their sleep. These technologies offer personalized insights, contributing to a holistic approach to sleep management. In conclusion, the Sleep Aid Market is a dynamic and rapidly evolving sector driven by a confluence of factors ranging from lifestyle changes and stress to aging demographics and technological innovations. As the awareness of the importance of sleep continues to grow, the market is poised for further expansion, with ongoing research and development focusing on providing diverse and effective solutions to meet the diverse needs of individuals striving for better sleep and overall well-being.

Key Market Drivers

Stress and lifestyle factors affecting sleep

The Sleeping Aids Market is experiencing significant growth driven by the pervasive impact of stress and lifestyle factors on sleep patterns. In the contemporary world, where high-stress levels and demanding lifestyles have become the norm, a growing number of individuals are grappling with sleep-related challenges. Stress, whether stemming from work pressures, societal expectations, or personal concerns, has emerged as a key contributor to sleep disturbances. This has led to an increased demand for sleeping aids as people seek effective solutions to alleviate stress-induced sleep problems and achieve better sleep quality.

Lifestyle factors also play a crucial role in shaping sleep patterns, and the modern way of life has introduced disruptions that adversely affect sleep. Irregular work hours, excessive screen time, and sedentary habits contribute to sleep disorders, creating a substantial market demand for interventions that address these lifestyle-induced sleep challenges. The prevalence of technology in daily life, particularly the use of electronic devices before bedtime, has been associated with disruptions in circadian rhythms, further complicating sleep. The link between stress, lifestyle factors, and sleep disorders has propelled individuals to explore a variety of sleeping aids to improve their sleep quality and overall well-being. This has led to a surge in the development of diverse sleep aid products, including over-the-counter medications, herbal supplements, and innovative sleep technologies.

The Sleeping Aids Market responds to the evolving needs of consumers seeking relief from stress-related sleep issues and disruptions caused by contemporary lifestyles. As awareness grows regarding the profound impact of quality sleep on physical and mental health, the market is poised to continue its expansion. Industry players are investing in research and development to introduce innovative sleep aid solutions that address the intricate interplay between stress, lifestyle, and sleep, offering individuals effective tools to achieve restful and rejuvenating sleep in the face of modern challenges.

Rise in mental health issues

The surge in mental health issues has emerged as a compelling driver propelling the growth of the Sleeping Aids Market. Mental health challenges, including anxiety, depression, and stress-related disorders, have a profound impact on sleep patterns, often leading to insomnia and other sleep disturbances. The intricate relationship between mental well-being and sleep quality has prompted individuals experiencing mental health issues to seek effective solutions to improve their sleep. The prevalence of mental health conditions, exacerbated by modern lifestyles and societal pressures, has contributed to a significant uptick in demand for sleeping aids. Individuals grappling with anxiety and stress often find it challenging to achieve restful sleep, leading to a negative cycle where sleep deprivation further exacerbates mental health issues. As a result, there is a growing recognition of the need for interventions that address both mental health concerns and sleep disorders.

Sleeping aids that offer dual benefits by addressing mental health issues and promoting better sleep have gained prominence in the market. This includes a range of products such as prescription medications, over-the-counter supplements, and therapeutic technologies designed to alleviate anxiety and induce relaxation, consequently improving sleep outcomes. The increased societal awareness and stigmatization of mental health discussions have prompted more individuals to seek professional help and explore complementary solutions to manage mental health challenges. As a consequence, the Sleeping Aids Market has witnessed a diversification of products tailored to meet the nuanced needs of individuals dealing with mental health-related sleep disruptions.

In response to this trend, industry players are focusing on developing innovative sleeping aids that incorporate elements of stress reduction, anxiety management, and relaxation techniques. The intersection of mental health and sleep has become a central consideration in the evolution of the Sleeping Aids Market, positioning it as a crucial component in the holistic approach to addressing mental well-being and promoting healthy sleep patterns.


Download Free Sample Report

Key Market Challenges

Limited long-term efficacy

Limited long-term efficacy poses a significant challenge for the Sleeping Aids Market. Many traditional sleep aids, including medications and supplements, may provide short-term relief but exhibit diminishing effectiveness over extended use. This challenge prompts individuals to seek sustainable solutions, considering potential tolerance and reduced efficacy over time. Innovations focusing on developing sleep aids with prolonged effectiveness, coupled with lifestyle modifications and behavioral interventions, are essential for addressing this challenge. Striking a balance between immediate relief and sustained efficacy remains a key consideration in the development and marketing of sleep aids, ensuring better outcomes for individuals dealing with chronic sleep issues.

Potential side effects

Potential side effects represent a noteworthy challenge for the Sleeping Aids Market. Various sleep aids, including medications and supplements, may entail side effects ranging from drowsiness and dizziness to more severe complications. These adverse effects often influence individuals' choices in seeking sleep aids, as concerns about safety and well-being become paramount. The market faces the challenge of balancing the efficacy of sleep aids with minimizing potential side effects, emphasizing the need for continuous research and development to produce safer alternatives. Stricter regulatory scrutiny and increased consumer awareness also underscore the importance of addressing this challenge for the sustainable growth of the market.

Dependency concerns

Dependency concerns present a significant challenge for the Sleeping Aids Market. Certain sleep aids, particularly prescription medications, may pose the risk of dependence or addiction if used regularly. The potential for individuals to develop a reliance on these aids to achieve sleep raises ethical and health concerns. Striking a balance between providing effective short-term relief and minimizing the risk of dependency is crucial for the market's credibility and long-term success. Ongoing research to develop non-habit-forming alternatives, coupled with education on responsible use, is essential to address this challenge and ensure the safe and responsible use of sleep aids.

Regulatory scrutiny

Regulatory scrutiny poses a significant challenge for the Sleeping Aids Market. Stringent regulations, especially for prescription medications, demand thorough safety and efficacy evaluations. Regulatory agencies closely monitor potential side effects, dependency risks, and long-term impacts of sleep aids. Any safety concerns may lead to restrictions or even withdrawal from the market. This scrutiny necessitates rigorous clinical trials, ongoing monitoring, and compliance with evolving regulatory standards. Striking a balance between innovation and meeting regulatory requirements is crucial for market players, highlighting the need for continuous collaboration between industry stakeholders and regulatory bodies to navigate these challenges and ensure the availability of safe and effective sleep aid options.

Key Market Trends

Growing demand for natural sleep aids

The growing demand for natural sleep aids signifies a prominent trend in the Sleeping Aids Market. Consumers are increasingly seeking alternatives to traditional medications, driven by a preference for holistic and sustainable solutions. Herbal supplements, plant-based formulations, and other natural remedies are gaining popularity due to perceived safety and reduced side effects. This trend aligns with the broader shift towards wellness and lifestyle-oriented healthcare choices. Industry players are responding by introducing a diverse range of natural sleep aids, capitalizing on the demand for products that resonate with the growing consciousness of health-conscious consumers seeking effective and nature-derived solutions for improved sleep quality.

Technological innovations in sleep-tracking devices

Technological innovations in sleep-tracking devices represent a noteworthy trend in the Sleeping Aids Market. The integration of advanced technology into wearables, smart mattresses, and sleep-tracking applications allows users to monitor and optimize their sleep patterns. These devices provide valuable insights into sleep quality, duration, and disturbances, empowering individuals to make informed lifestyle adjustments for better sleep. The trend underscores a shift towards a more proactive and personalized approach to sleep management, reflecting the growing intersection of technology and healthcare. As consumer interest in health monitoring rises, sleep-tracking devices are becoming integral components of comprehensive sleep aid solutions.

Increasing focus on personalized sleep solutions

The trend of increasing focus on personalized sleep solutions is reshaping the Sleeping Aids Market. Recognizing that sleep patterns are highly individualized, there is a growing emphasis on tailored interventions. From customizable mattress options to personalized sleep apps and genetic testing for sleep-related traits, the market is witnessing a shift towards precision medicine in addressing sleep issues. This trend aligns with the broader healthcare paradigm of delivering individualized care. Industry players are investing in research and development to offer innovative and customized sleep aid solutions that cater to the specific needs and preferences of consumers, enhancing the overall effectiveness of sleep interventions.

Rise in OTC sleep aid options

The trend of a rising number of over-the-counter (OTC) sleep aid options is shaping the Sleeping Aids Market. Consumers seek accessible and convenient solutions without prescription requirements, driving the proliferation of OTC sleep aids. These options often include herbal supplements, melatonin-based products, and other non-prescription formulations. The trend reflects a shift towards self-directed healthcare, empowering individuals to address sleep issues independently. Industry response to this demand involves expanding and diversifying OTC sleep aid offerings, providing a broader range of choices for consumers seeking effective and readily available solutions to enhance their sleep quality and overall well-being.

Segmental Insights

Sleep Disorder Insights

Based on the Sleep Disorder, Insomnia's dominance in the Sleeping Aids Market is evident due to its widespread prevalence and impact on individuals' daily lives. As a common sleep disorder characterized by difficulty falling or staying asleep, insomnia prompts a significant demand for sleep aids. Prescription medications, over-the-counter remedies, and natural supplements are sought after by those experiencing insomnia to alleviate their sleep disturbances. The market's focus on developing diverse and effective solutions for insomnia underscores its pivotal role in shaping the landscape of sleep aid interventions, catering to the substantial population seeking relief from this pervasive sleep disorder.

Distribution Channel Insights

Based on distribution channel, Hospital pharmacies play a dominant role in the Sleeping Aids Market, serving as crucial distribution points for prescription sleep aids and medications. Patients seeking medical intervention for sleep disorders often receive prescriptions through hospital healthcare providers. The controlled and regulated environment of hospital pharmacies ensures the safe dispensing of sleep aids, including potent medications that require professional oversight. Hospitals provide a comprehensive approach to sleep disorder management, often incorporating counseling and diagnostics. The prominence of hospital pharmacies underscores their integral position in the sleep aid supply chain, emphasizing the importance of healthcare settings in addressing sleep-related issues.


Download Free Sample Report

Regional Insights

Based on region, North America stands as the dominant force in the Sleeping Aids Market, driven by a combination of factors. The region's robust healthcare infrastructure, high prevalence of sleep disorders, and significant consumer awareness contribute to its leadership. Advanced research and development initiatives, coupled with a favorable regulatory environment, position North America at the forefront of sleep aid innovation. The presence of key market players, proactive healthcare policies, and a growing emphasis on holistic well-being further solidify North America's dominance. With a substantial market share, the region continues to shape the trajectory of the global Sleeping Aids Market.

Key Market Players

  • AstraZeneca Plc
  • BMC Medical Co., Ltd.
  • Cadwell Industries, Inc
  • Compumedics Limited
  • Drive DeVilbiss Healthcare Inc
  • Eisai Co. Ltd.
  • Fisher & Paykel Healthcare Limited
  • GlaxoSmithKline Plc
  • Idorsia Pharmaceuticals Ltd
  • Koninklijke Philips N.V

By Product Type

By Sleep Disorder

By Distribution Channel

By Region

  • Mattresses & Pillows
  • Medications
  • Sleep Apnea Devices
  • Others
  • Insomnia
  • Narcolepsy
  • Restless Leg Syndrome
  • Sleep Apnea
  • Others
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-commerce
  • Drug Stores
  • Others
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

 

Report Scope:

In this report, the Global Sleeping Aids Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Sleeping Aids Market, By Product Type:

o   Mattresses & Pillows

o   Medications

o    Sleep Apnea Devices

o   Others

  • Sleeping Aids Market, By Sleep Disorder:

o   Insomnia

o   Narcolepsy Restless Leg Syndrome

o   Sleep Apnea

o   Others

  • Sleeping Aids Market, By Distribution Channel:

o   Hospital Pharmacies

o   Retail Pharmacies

o   E-commerce

o   Drug Stores

o   Others

  • Sleeping Aids Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Sleeping Aids Market.

Available Customizations:

Global Sleeping Aids market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Sleeping Aids Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Global Sleeping Aids Market Outlook

4.1.  Market Size & Forecast

4.1.1.        By Value

4.2.  Market Share & Forecast

4.2.1.        By Product Type (Mattresses & Pillows, Medications, Sleep Apnea Devices, Others)

4.2.2.        By Sleep Disorder (Insomnia, Narcolepsy, Restless Leg Syndrome, Sleep Apnea, Others)

4.2.3.        By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-commerce, Drug Stores, Others)

4.2.4.        By Region

4.2.5.        By Company (2023)

4.3.  Market Map

4.3.1.        By Product Type

4.3.2.        By Sleep Disorder

4.3.3.        By Distribution Channel

4.3.4.        By Region

5.    Asia Pacific Sleeping Aids Market Outlook

5.1. Market Size & Forecast

5.1.1.    By Value

5.2. Market Share & Forecast

5.2.1.    By Product Type

5.2.2.    By Sleep Disorder 

5.2.3.    By Distribution Channel

5.2.4.    By Country

5.3.  Asia Pacific: Country Analysis

5.3.1.  China Sleeping Aids Market Outlook

5.3.1.1.        Market Size & Forecast

5.3.1.1.1.           By Value

5.3.1.2.        Market Share & Forecast

5.3.1.2.1.           By Product Type

5.3.1.2.2.           By Sleep Disorder 

5.3.1.2.3.           By Distribution Channel

5.3.2.  India Sleeping Aids Market Outlook

5.3.2.1.        Market Size & Forecast

5.3.2.1.1.           By Value

5.3.2.2.        Market Share & Forecast

5.3.2.2.1.           By Product Type

5.3.2.2.2.           By Sleep Disorder 

5.3.2.2.3.           By Distribution Channel

5.3.3.  Australia Sleeping Aids Market Outlook

5.3.3.1.        Market Size & Forecast

5.3.3.1.1.           By Value

5.3.3.2.        Market Share & Forecast

5.3.3.2.1.           By Product Type

5.3.3.2.2.           By Sleep Disorder 

5.3.3.2.3.           By Distribution Channel

5.3.4.    Japan Sleeping Aids Market Outlook

5.3.4.1.        Market Size & Forecast

5.3.4.1.1.           By Value

5.3.4.2.        Market Share & Forecast

5.3.4.2.1.           By Product Type

5.3.4.2.2.           By Sleep Disorder 

5.3.4.2.3.           By Distribution Channel

5.3.5.    South Korea Sleeping Aids Market Outlook

5.3.5.1.        Market Size & Forecast

5.3.5.1.1.           By Value

5.3.5.2.        Market Share & Forecast

5.3.5.2.1.           By Product Type

5.3.5.2.2.           By Sleep Disorder 

5.3.5.2.3.           By Distribution Channel

6.    Europe Sleeping Aids Market Outlook

6.1.  Market Size & Forecast

6.1.1.  By Value

6.2.  Market Share & Forecast

6.2.1.  By Product Type

6.2.2.  By Sleep Disorder 

6.2.3.  By Distribution Channel

6.2.4.  By Country

6.3.  Europe: Country Analysis

6.3.1.  France Sleeping Aids Market Outlook

6.3.1.1.      Market Size & Forecast

6.3.1.1.1.           By Value

6.3.1.2.        Market Share & Forecast

6.3.1.2.1.           By Product Type

6.3.1.2.2.           By Sleep Disorder 

6.3.1.2.3.           By Distribution Channel

6.3.2.    Germany Sleeping Aids Market Outlook

6.3.2.1.        Market Size & Forecast

6.3.2.1.1.           By Value

6.3.2.2.        Market Share & Forecast

6.3.2.2.1.           By Product Type

6.3.2.2.2.           By Sleep Disorder 

6.3.2.2.3.           By Distribution Channel

6.3.3.    Spain Sleeping Aids Market Outlook

6.3.3.1.        Market Size & Forecast

6.3.3.1.1.           By Value

6.3.3.2.        Market Share & Forecast

6.3.3.2.1.           By Product Type

6.3.3.2.2.           By Sleep Disorder 

6.3.3.2.3.           By Distribution Channel

6.3.4.    Italy Sleeping Aids Market Outlook

6.3.4.1.        Market Size & Forecast

6.3.4.1.1.           By Value

6.3.4.2.        Market Share & Forecast

6.3.4.2.1.           By Product Type

6.3.4.2.2.           By Sleep Disorder 

6.3.4.2.3.           By Distribution Channel

6.3.5.    United Kingdom Sleeping Aids Market Outlook

6.3.5.1.        Market Size & Forecast

6.3.5.1.1.           By Value

6.3.5.2.        Market Share & Forecast

6.3.5.2.1.           By Product Type

6.3.5.2.2.           By Sleep Disorder 

6.3.5.2.3.           By Distribution Channel

7.    North America Sleeping Aids Market Outlook

7.1.  Market Size & Forecast

7.1.1.        By Value

7.2.  Market Share & Forecast

7.2.1.        By Product Type

7.2.2.        By Sleep Disorder

7.2.3.        By Distribution Channel

7.2.4.        By Country

7.3.  North America: Country Analysis

7.3.1.      United States Sleeping Aids Market Outlook

7.3.1.1.  Market Size & Forecast

7.3.1.1.1.     By Value

7.3.1.2.  Market Share & Forecast

7.3.1.2.1.     By Product Type

7.3.1.2.2.     By Sleep Disorder 

7.3.1.2.3.     By Distribution Channel

7.3.2.        Mexico Sleeping Aids Market Outlook

7.3.2.1.  Market Size & Forecast

7.3.2.1.1.     By Value

7.3.2.2.  Market Share & Forecast

7.3.2.2.1.       By Product Type

7.3.2.2.2.       By Sleep Disorder 

7.3.2.2.3.       By Distribution Channel

7.3.3.        Canada Sleeping Aids Market Outlook

7.3.3.1.    Market Size & Forecast

7.3.3.1.1.         By Value

7.3.3.2.      Market Share & Forecast

7.3.3.2.1.       By Product Type

7.3.3.2.2.       By Sleep Disorder 

7.3.3.2.3.       By Distribution Channel

8.    South America Sleeping Aids Market Outlook

8.1.  Market Size & Forecast

8.1.1.      By Value

8.2.  Market Share & Forecast

8.2.1.      By Product Type

8.2.2.      By Sleep Disorder 

8.2.3.      By Distribution Channel

8.2.4.      By Country

8.3.  South America: Country Analysis

8.3.1.      Brazil Sleeping Aids Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.     By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.     By Product Type

8.3.1.2.2.     By Sleep Disorder 

8.3.1.2.3.     By Distribution Channel

8.3.2.        Argentina Sleeping Aids Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.     By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.     By Product Type

8.3.2.2.2.     By Sleep Disorder 

8.3.2.2.3.     By Distribution Channel

8.3.3.      Colombia Sleeping Aids Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.     By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.     By Product Type

8.3.3.2.2.     By Sleep Disorder 

8.3.3.2.3.     By Distribution Channel

9.    Middle East and Africa Sleeping Aids Market Outlook

9.1.  Market Size & Forecast

9.1.1.        By Value

9.2.  Market Share & Forecast

9.2.1.      By Product Type

9.2.2.      By Sleep Disorder 

9.2.3.      By Distribution Channel

9.2.4.      By Country

9.3.  MEA: Country Analysis

9.3.1.        South Africa Sleeping Aids Market Outlook

9.3.1.1.          Market Size & Forecast

9.3.1.1.1.     By Value

9.3.1.2.          Market Share & Forecast

9.3.1.2.1.     By Product Type

9.3.1.2.2.     By Sleep Disorder 

9.3.1.2.3.     By Distribution Channel

9.3.2.    Saudi Arabia Sleeping Aids Market Outlook

9.3.2.1.          Market Size & Forecast

9.3.2.1.1.     By Value

9.3.2.2.          Market Share & Forecast

9.3.2.2.1.     By Product Type

9.3.2.2.2.     By Sleep Disorder 

9.3.2.2.3.     By Distribution Channel

9.3.3.    UAE Sleeping Aids Market Outlook

9.3.3.1.          Market Size & Forecast

9.3.3.1.1.       By Value

9.3.3.2.          Market Share & Forecast

9.3.3.2.1.       By Product Type

9.3.3.2.2.       By Sleep Disorder 

9.3.3.2.3.       By Distribution Channel

10. Market Dynamics

10.1.   Drivers

10.2.   Challenges

11. Market Trends & Developments

11.1.   Recent Developments

11.2.   Product Launches

11.3.   Mergers & Acquisitions

12. Global Sleeping Aids Market: SWOT Analysis

13. Porter’s Five Forces Analysis

13.1.   Competition in the Industry

13.2.   Potential of New Entrants

13.3.   Power of Suppliers

13.4.   Power of Customers

13.5.   Threat of Substitute Product

14. Competitive Landscape

14.1.   AstraZeneca Plc

14.1.1.      Business Overview

14.1.2.      Company Snapshot

14.1.3.      Product  & Services

14.1.4.      Financials (In case of listed)

14.1.5.      Recent Developments

14.1.6.      SWOT Analysis

14.2.   BMC Medical Co., Ltd.

14.3.   Cadwell Industries, Inc

14.4.   Compumedics Limited

14.5.   Drive DeVilbiss Healthcare Inc

14.6.   Eisai Co. Ltd.

14.7.   Fisher & Paykel Healthcare Limited

14.8.   GlaxoSmithKline Plc

14.9.   Idorsia Pharmaceuticals Ltd

14.10.Koninklijke Philips N.V

15. Strategic Recommendations

16. About Us & Disclaimer

Figures and Tables

Frequently asked questions

down-arrow

The market size of the Global Sleeping Aids Market was estimated to be USD 62.12 Billion in 2023.

down-arrow

Sleeping aids are products or medications designed to alleviate sleep-related issues. They include prescription and over-the-counter medications, herbal supplements, and technological devices aimed at improving sleep quality and duration.

down-arrow

AstraZeneca Plc, BMC Medical Co., Ltd, Cadwell Industries, Inc, Compumedics Limited, Drive DeVilbiss Healthcare Inc, Eisai Co. Ltd. , Fisher & Paykel Healthcare Limited, GlaxoSmithKline Plc, Idorsia Pharmaceuticals Ltd, Koninklijke Philips N.V etc. were the top players operating in the Global Sleeping Aids Market in 2023.

down-arrow

Major drivers for the Global Sleeping Aids Market include the rising prevalence of sleep disorders, growing awareness of the importance of sleep, lifestyle factors affecting sleep, increasing aging population, and technological advancements.

profile

Sakshi Bajaal

Business Consultant
Press Release

Sleeping Aids Market to Grow with a CAGR of 6.45% through 2029

May, 2024

Increasing prevalence of sleep disorders and Growing awareness of the importance of sleep are factors driving the Global Sleeping Aids Market in the forecast period 2025-2029.